US Bancorp’s STAAR Surgical STAA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $54.8K | Buy |
1,910
+213
| +13% | +$5.92K | ﹤0.01% | 2744 |
|
|
2026
Q1 | $31.7K | Sell |
1,697
-604
| -26% | -$11.5K | ﹤0.01% | 2905 |
|
|
2025
Q4 | $53.1K | Hold |
2,301
| – | – | ﹤0.01% | 2668 |
|
|
2025
Q3 | $61.8K | Buy |
2,301
+250
| +12% | +$5.96K | ﹤0.01% | 2572 |
|
|
2025
Q2 | $34.4K | Buy |
2,051
+7
| +0.3% | +$123 | ﹤0.01% | 2951 |
|
|
2025
Q1 | $36K | Buy |
2,044
+1,930
| +1,693% | +$38.7K | ﹤0.01% | 2899 |
|
|
2024
Q4 | $2.77K | Sell |
114
-308
| -73% | -$8.79K | ﹤0.01% | 3795 |
|
|
2024
Q3 | $15.7K | Sell |
422
-93
| -18% | -$3.47K | ﹤0.01% | 3213 |
|
|
2024
Q2 | $24.5K | Hold |
515
| – | – | ﹤0.01% | 2979 |
|
|
2024
Q1 | $19.7K | Buy |
515
+249
| +94% | +$8.1K | ﹤0.01% | 3104 |
|
|
2023
Q4 | $8.3K | Sell |
266
-298
| -53% | -$10.7K | ﹤0.01% | 3364 |
|
|
2023
Q3 | $22.7K | Buy |
564
+410
| +266% | +$19.2K | ﹤0.01% | 2815 |
|
|
2023
Q2 | $8.1K | Sell |
154
-2,634
| -94% | -$160K | ﹤0.01% | 3335 |
|
|
2023
Q1 | $178K | Sell |
2,788
-307
| -10% | -$20K | ﹤0.01% | 1917 |
|
|
2022
Q4 | $150K | Sell |
3,095
-5,238
| -63% | -$329K | ﹤0.01% | 2009 |
|
|
2022
Q3 | $587K | Buy |
8,333
+4,914
| +144% | +$421K | ﹤0.01% | 1319 |
|
|
2022
Q2 | $243K | Buy |
3,419
+684
| +25% | +$44.1K | ﹤0.01% | 1795 |
|
|
2022
Q1 | $219K | Buy |
2,735
+520
| +23% | +$38.7K | ﹤0.01% | 1910 |
|
|
2021
Q4 | $203K | Sell |
2,215
-313
| -12% | -$33.6K | ﹤0.01% | 1968 |
|
|
2021
Q3 | $325K | Buy |
2,528
+71
| +3% | +$9.94K | ﹤0.01% | 1739 |
|
|
2021
Q2 | $375K | Sell |
2,457
-11
| -0.4% | -$1.45K | ﹤0.01% | 1691 |
|
|
2021
Q1 | $260K | Sell |
2,468
-756
| -23% | -$75.7K | ﹤0.01% | 1806 |
|
|
2020
Q4 | $255K | Sell |
3,224
-269
| -8% | -$19.7K | ﹤0.01% | 1764 |
|
|
2020
Q3 | $198K | Buy |
3,493
+44
| +1% | +$2.37K | ﹤0.01% | 1775 |
|
|
2020
Q2 | $212K | Hold |
3,449
| – | – | ﹤0.01% | 1729 |
|
|
2020
Q1 | $111K | Buy |
3,449
+566
| +20% | +$19.1K | ﹤0.01% | 1971 |
|
|
2019
Q4 | $101K | Buy |
2,883
+558
| +24% | +$18.4K | ﹤0.01% | 2170 |
|
|
2019
Q3 | $60K | Buy |
2,325
+1,325
| +133% | +$40.3K | ﹤0.01% | 2375 |
|
|
2019
Q2 | $29K | Hold |
1,000
| – | – | ﹤0.01% | 2753 |
|
|
2019
Q1 | $34K | Sell |
1,000
-37
| -4% | -$1.31K | ﹤0.01% | 2658 |
|
|
2018
Q4 | $33K | Hold |
1,037
| – | – | ﹤0.01% | 2631 |
|
|
2018
Q3 | $50K | Buy |
1,037
+37
| +4% | +$1.51K | ﹤0.01% | 2555 |
|
|
2018
Q2 | $31K | Hold |
1,000
| – | – | ﹤0.01% | 2788 |
|
|
2018
Q1 | $15K | Hold |
1,000
| – | – | ﹤0.01% | 3040 |
|
|
2017
Q4 | $16K | Hold |
1,000
| – | – | ﹤0.01% | 3005 |
|
|
2017
Q3 | $12K | Hold |
1,000
| – | – | ﹤0.01% | 3046 |
|
|
2017
Q2 | $11K | Hold |
1,000
| – | – | ﹤0.01% | 3040 |
|
|
2017
Q1 | $10K | Hold |
1,000
| – | – | ﹤0.01% | 3037 |
|
|
2016
Q4 | $11K | Hold |
1,000
| – | – | ﹤0.01% | 3005 |
|
|
2016
Q3 | $9K | Buy |
+1,000
| New | +$8.03K | ﹤0.01% | 3030 |
|
Other funds holding STAA
BC
MAP
YC
AIM
US Bancorp's STAA Position: Q2 2026 in Review
US Bancorp increased its STAAR Surgical (STAA) stake by 13% in Q2 2026, buying an estimated $5.92K and bringing the position to 1,910 shares worth $54.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2744.
US Bancorp first reported a position in STAA in Q3 2016 and has held it in 40 quarters since. The position peaked at $587K in Q3 2022. 200 funds tracked by Wall St. Rank hold STAA as of Q2 2026.
- US Bancorp held 1,910 shares of STAAR Surgical worth $54.8K as of Q2 2026.
- US Bancorp bought 213 STAAR Surgical shares in Q2 2026, an estimated $5.92K.
- STAAR Surgical made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #2744 holding.
- US Bancorp first reported a position in STAAR Surgical in Q3 2016 and has held it in 40 quarters since.
- US Bancorp's STAAR Surgical position peaked at $587K in Q3 2022.
- 200 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2026.
Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.